NCT03986320View on ClinicalTrials.gov

Evaluation of the Effectiveness and Safety of Keeogo™ Dermoskeleton in Subjects With Mobility Impairments Due to Stroke

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

September 30, 2020

Conditions
Stroke, IschemicStroke HemorrhagicStrokeHemiparesisCerebral Vascular Accident
Interventions
DEVICE

Keeogo™ Dermoskeleton

This device is intended for use in rehabilitation institutions to assist individuals with hemiparesis due to stroke who are able to stand and initiate a step in performing ambulatory functions.

Trial Locations (4)

10468

James J Peters VA Medical Center - Center for the Medical Consequences of Spinal Cord Injury, The Bronx

60611

Shirley Ryan Ability Lab (SRA), Chicago

07052

Human Performance and Engineering Research (HPER), West Orange

M6A 2E1

Assistive Technology Clinic (ATC), Toronto

Sponsors

Lead Sponsor

B-Temia, Inc.
All Listed Sponsors
lead

B-Temia, Inc.

INDUSTRY

NCT03986320 - Evaluation of the Effectiveness and Safety of Keeogo™ Dermoskeleton in Subjects With Mobility Impairments Due to Stroke | Biotech Hunter | Biotech Hunter